• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

140
17
14
14
10

COUNTRY

14
3
2
1
1

PRICE

86
139
203
385

PUBLISHED

1
9
68
385

PRODUCT TYPE

371
10
4

Respiratory

Respiratory drugs and is a growing sector of the pharmaceuticals industry, and we have all the information resources that you need to be a leading player in this lucrative market. The publications listed under Research and Markets’ Respiratory category cover all drugs and therapeutics for conditions and diseases relating to the lungs and/or breathing, such as Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, COPD (chronic obstructive pulmonary disease), cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, sleep apnea and others.

Our reports, books, and subscriptions will provide you with the latest industry news, forecasts, market trends and company profiles of market leaders and niche players including: Accentia Biopharmaceuticals, Aerogen, Aerovance, airPharma, AstraZeneca, Aventis Pharma, Bespak, Boehringer Ingelheim Pharmaceuticals, Cadila Pharmaceuticals, Dr. Reddys Laboratories, EvoGenix, GlaxoSmithKlineInyx, The Merck Generics Group, Novartis AG, Pfizer, Ranbaxy Laboratories, Respironics, Sandoz International, Schering-Plough, etc.

Publications on smoking cessation are listed under the OTC sub-category in the Pharmaceuticals section. Show Less
Read more

PRODUCT TITLE

Acute Lung Injury - Pipeline Review, H1 2013

Acute Lung Injury – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Lung Injury - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

May 2013
FROM

Allergic Asthma - Pipeline Review, H1 2013

Allergic Asthma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Allergic Asthma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

May 2013
FROM

Pulmonary Fibrosis - Pipeline Review, H1 2013

Pulmonary Fibrosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

May 2013
FROM

Respiratory Distress Syndrome - Pipeline Review, H1 2013

Respiratory Distress Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Respiratory Distress Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

May 2013
FROM

Respiratory Tract Infections - Pipeline Review, H1 2013

Respiratory Tract Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Respiratory Tract Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

May 2013
FROM

Lung Injury - Pipeline Review, H1 2013

Lung Injury – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Lung Injury - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Pediatric Respiratory Syncytial...

April 2013
FROM
Sleep Apnea - Pipeline Review, H1 2013 Sleep Apnea - Pipeline Review, H1 2013 - Product Thumbnail Image

Sleep Apnea - Pipeline Review, H1 2013

Sleep Apnea – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sleep Apnea - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM

OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 Summary Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia...

April 2013
FROM

Lung Injury Global Clinical Trials Review, H1, 2013

Lung Injury Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2013" provides data on the Lung Injury clinical trial scenario...

April 2013
FROM

Synagis (Pediatric RSV) - Forecast and Market Analysis to 2022

Synagis (Pediatric RSV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Synagis (Pediatric RSV) - Forecast and Market Analysis to...

April 2013
FROM

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2013

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2013" provides data on the...

April 2013
FROM

Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2013

Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2013" provides data...

April 2013
FROM

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick,...

April 2013
FROM

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022 Summary Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory...

April 2013
FROM
Bronchopulmonary Dysplasia - Pipeline Review, H1 2013 Bronchopulmonary Dysplasia - Pipeline Review, H1 2013 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Pipeline Review, H1 2013

Bronchopulmonary Dysplasia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bronchopulmonary Dysplasia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Diphtheria - Pipeline Review, H1 2013 Diphtheria - Pipeline Review, H1 2013 - Product Thumbnail Image

Diphtheria - Pipeline Review, H1 2013

Diphtheria – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diphtheria - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM

Bronchospasm Global Clinical Trials Review, H1, 2013

Bronchospasm Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2013" provides data on the Bronchospasm clinical trial scenario....

April 2013
FROM

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily...

April 2013
FROM
Cystic Fibrosis - Pipeline Review, H1 2013 Cystic Fibrosis - Pipeline Review, H1 2013 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Review, H1 2013

Cystic Fibrosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cystic Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos